# ForSight Robotics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/forsight-robotics

- Industry: Medical Devices & Equipment
- Headquarters: Haifa, Israel
- Website: www.forsightrobotics.com
- Total disclosed funding: $190M
- Latest round: Series B (Jun 24, 2025)
- Investors on record: 6

## About

Founded in 2020 in Haifa, Israel, ForSight Robotics Ltd. focuses on revolutionizing ophthalmic surgery with its innovative ORYOM platform, integrating robotics and advanced data analytics to enhance surgical precision and accessibility for eye care providers. ForSight Robotics Ltd. is dedicated to improving ophthalmic surgery through its flagship product, the ORYOM platform. The company was co-founded by Daniel Glozman and Joseph Nathan, with Glozman currently serving as CEO. ForSight Robotics specializes in advancing ophthalmic surgery through its flagship product, the ORYOM platform, which is the first hybrid intraocular robotic ophthalmic platform designed to enhance surgical precision and accessibility. The ORYOM platform integrates high-precision robotics, advanced visualization technology, and cognitive data analytics to facilitate both curative and preventative ophthalmic surgeries, including cataract treatment, glaucoma management, and retinal disease interventions. This technology addresses the pressing demand for surgical eye care amidst a shortage of trained eye surgeons, aiming to improve surgical outcomes and reduce the burden on healthcare providers. The primary users of the ORYOM platform include hospitals, surgical centers, and eye care clinics, particularly in North America, Europe, and select markets in Asia, where the need for enhanced eye care solutions is significant.ForSight Robotics operates on a business model that primarily involves partnerships with healthcare institutions and surgical facilities. The revenue structure is based on direct sales or leasing agreements for the ORYOM platform, along with potential service subscriptions for maintenance and upgrades. Clients, such as hospitals and surgical centers, may engage in multi-year contracts that include comprehensive support and training for their staff on the use of the ORYOM system. The company's revenue is derived from both the sale of the robotic systems and ongoing service agreements, reinforcing the platform’s role in the modern surgical landscape. In June 2025, ForSight Robotics Ltd. raised USD 125 million in Series B funding led by Eclipse Ventures, with participation from Reiya Ventures and Adani Group.

## Funding rounds

- Series B, Jun 24, 2025, $125M — Adani Group, Eclipse Ventures, Reiya Ventures
- Series A, Jul 18, 2022, $55M — Precision Capital, Mithril, Adani Group, Eclipse Ventures, Provenio Capital, Reiya Ventures
- Seed, Mar 9, 2021, $10M — Mithril, Eclipse Ventures

## Investors

- Mithril (https://capitalatlas.ai/funds/mithril) — Seed, Series A
- Eclipse Ventures (https://capitalatlas.ai/funds/eclipse-ventures) — Seed, Series A, Series B
- Precision Capital (https://capitalatlas.ai/funds/precision-capital) — Series A
- Adani Group — Series A, Series B
- Provenio Capital — Series A
- Reiya Ventures — Series A, Series B